Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
2006
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
A Significant Role of Human Cytochrome P450 2C8 in Amiodarone N-Deethylation: An Approach to Predict the Contribution with Relative Activity Factor
2000
Microwave chemistry for inorganic nanomaterials synthesis
2010 Standout
Oral Bioavailability of Posaconazole in Fasted Healthy Subjects
2005
Human P450 metabolism of warfarin
1997
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Clinically Important Drug Interactions with Anticoagulants
1996
Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection
2007
Microwave‐enhanced enzyme reaction for protein mapping by mass spectrometry: A new approach to protein digestion in minutes
2002
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
2013 StandoutNature
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites
2010
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion
2007 Standout
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
1999 Standout
Identification of the Mitochondrial Targeting Signal of the Human Equilibrative Nucleoside Transporter 1 (hENT1)
2006
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Structural Forms of Phenprocoumon and Warfarin That Are Metabolized at the Active Site of CYP2C9
1999
Albumin–drug interaction and its clinical implication
2013 Standout
Microwaves in organic synthesis. Thermal and non-thermal microwave effects
2005 Standout
Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor
2004
Adverse Effects of Amiodarone
1998
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
2011
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9
2005
Posaconazole: clinical pharmacology and potential for management of fungal infections
2005
Covalent organic frameworks (COFs): from design to applications
2012 Standout
Better therapeutics through microarrays
2002
Posaconazole: a broad-spectrum triazole antifungal
2005
Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
2007
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Cascade Reactions in Total Synthesis
2006 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
1998
A Ligand‐Library Approach to the Highly Efficient Rhodium/Phosphoramidite‐Catalyzed Asymmetric Arylation of N,N‐Dimethylsulfamoyl‐Protected Aldimines
2006 StandoutNobel
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Drug glucuronidation in humans
1991
The Transcriptional Regulation of the Human CYP2C Genes
2009
Comparative Pharmacokinetics of Vitamin K Antagonists
2005
Enzyme induction in the cytochrome P-450 system
1990 Standout
Herb-Drug Interactions
2005 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Inhibition and induction of human cytochrome P450 (CYP) enzymes
1998
Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction
2004
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs
2004
Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes
2004
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Can a Ketone Be More Reactive than an Aldehyde? Catalytic Asymmetric Synthesis of Substituted Tetrahydrofurans
2018 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon
2008
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herbSalvia miltiorrhiza
2006
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
2012
Mass Spectrometry
1998
In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.
2001
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Electrospray mass spectrometry of fossil fuels
2000 StandoutNobel
Correlation of placental microsomal activities with protein detected by antibodies to rabbit cytochrome P-450 isozyme 6 in preparations from humans exposed to polychlorinated biphenyls, quaterphenyls, and dibenzofurans.
1986
Polycyclic Polyprenylated Acylphloroglucinols
2006 Standout
Posaconazole: A Next-Generation Triazole Antifungal
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Amide bond formation and peptide coupling
2005 Standout
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Catalytic Asymmetric Transfer Hydrogenation of α-Ketoesters with Hantzsch Esters
2006 StandoutNobel
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Microwave-assisted acid hydrolysis of proteins combined with liquid chromatography MALDI MS/MS for protein identification
2005
Engineered Bacterial Mimics of Human Drug Metabolizing Enzyme CYP2C9
2011 StandoutNobel
Metalated Heterocycles and Their Applications in Synthetic Organic Chemistry
2004
ASPECTS OF ANTICOAGULANT ACTION: A Review of the Pharmacology, Metabolism and Toxicology of Warfarin and Congeners
1987
Functional Oligothiophenes: Molecular Design for Multidimensional Nanoarchitectures and Their Applications
2009 Standout
Kontrolliertes Erhitzen mit Mikrowellen in der modernen organischen Synthese
2004
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Applications of isotope dilution‐mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology
1992
Rapid cyclopeptide analysis by microwave enhanced Akabori reaction
2003
Asymmetric Catalysis via Cyclic, Aliphatic Oxocarbenium Ions
2017 StandoutNobel
Interactions of Warfarin with Drugs and Food
1994
A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
1997
Direct Asymmetric Michael Reactions of Cyclic 1,3-Dicarbonyl Compounds and Enamines Catalyzed by Chiral Bisoxazoline−Copper(II) Complexes
2003
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
1998
Catalytic Asymmetric Bromoetherification and Desymmetrization of Olefinic 1,3-Diols with C2-Symmetric Sulfides
2014
Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics
2015 Standout
Pharmacogenetic Determinants of Codeine Induction by Rifampin: The Impact on Codeine’s Respiratory, Psychomotor and Miotic Effects
1997
CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
2005
Characteristics of the amiodarone–warfarin interaction during long-term follow-up
2008
Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
1999
Works of Larry Heimark being referenced
Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.
1989
Chiral high-performance liquid chromatographic analysis of antifungal SCH 56592 and evaluation of its chiral inversion in animals and humans
2000
Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometry
1997
The mechanism of the interaction between amiodarone and warfarin in humans
1992
Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis
2002
Tricyclic thienopyridine–pyrimidones/thienopyrimidine–pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain
2009
The mechanism of the warfarin-rifampin drug interaction in humans
1987
Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase
1999
Microwave enhanced akabori reaction for peptide analysis
2002
Stereoselective and regioselective hydroxylation of warfarin and selective O-dealkylation of phenoxazone ethers in human placenta
1985
The synthesis of deuterium labelled metabolites of warfarin and phenprocoumon
1986
The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans
1987
Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and Molds
2004
A stable isotope assay for phenprocoumon and its metabolites
1985
The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system
1984
Metabolic Fate of Phenprocoumon in Humans
1985
Stereoselective metabolism of conformational analogs of warfarin by .beta.-naphthoflavone-inducible cytochrome P-450
1985